Calyxha Biotechnologies announces grant of a European Patent on neurodegenerative diseases
Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories. “Calyxha’s approach to drug development is […]
Continue Reading